Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...

Scotiabank analyst Nick Altmann maintained a Hold rating on Confluent (CFLT – Research Report) today and set a price target of $27.00. The ...

JMP Securities analyst Patrick Walravens maintained a Buy rating on Confluent (CFLT – Research Report) today and set a price target of $40.00.

TD Cowen analysts showed continued confidence in Confluent Inc (NASDAQ:CFLT), raising the company's price target from $31.00 to $37.00 while maintaining a Buy rating. The adjustment comes ahead of ...

Stay up to date on Confluent analyst ratings. Delving into Confluent's Background Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This translated to sustained momentum in new logo acquisition and customer expansions." On the profitability front, we note that Confluent achieved a record pro forma operating margin of 6% in the ...

As such, this is a guest post written by Peter Pugh-Jones, in his capacity as director of strategic accounts at Confluent. Understanding how the cadence and throughput of real-time data impacts ...

Confluent (NASDAQ:CFLT) shares fell 3% in premarket trading on Thursday after Morgan Stanley downgraded the streaming technology company. "We remain believers that the data streaming platform ...